The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity

Keywords

KRASCancer researchPharmacologyImmune systemMedicineCancerImmunologyColorectal cancerInternal medicine

Affiliated Institutions

Related Publications

T cell receptor-dependent, antigen-specific stimulation of a murine T cell clone induces a transient, VLA protein-mediated binding to extracellular matrix

B M Chan , J G Wong , Arvind Rao +1 more

Abstract Upon Ag stimulation, an arsonate-specific murine T cell clone exhibited a rapid but transient increase in cell adhesion to collagen, fibronectin, and laminin. This incr...

1991 The Journal of Immunology 124 citations

Signaling by vascular cell adhesion molecule‐1 (VCAM‐1) through VLA‐4 promotes CD3‐dependent T cell proliferation

Linda C. Burkly , Aniela Jakubowski , Barbara M. Newman +3 more

Abstract Vascular cell adhesion molecule, VCAM‐1, is an adhesion molecule expressed on activated endothelium thought to play a role in leukocyte migration to sites of inflammati...

1991 European Journal of Immunology 131 citations

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan , Shannon J. Turley , Dorothee Nickles +39 more

2018 Nature 5078 citations

Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation.

Donald Küfe , L M Nadler , Lalla Sargent +5 more

The cell surface-binding properties of two murine monoclonal antibodies reactive with human mammary tumor cells are described. Fluorescence-activated cell sorter analyses demons...

1983 PubMed 86 citations

Theophylline in the management of asthma: time for reappraisal?

Peter J. Barnes , RA Pauwels

Theophylline has been used for several decades in the treatment of asthma and remains the most widely prescribed anti-asthma drug worldwide, although the development of newer an...

1994 European Respiratory Journal 276 citations

Publication Info

Year: 2019
Type: article
Volume: 575
Issue: 7781
Pages: 217-223
Citations: 2068
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2068

OpenAlex

Cite This

APA Style

                            
                                
                                    Jude Canon, 
                                
                                    Karen Rex, 
                                
                                    Anne Y. Saiki
                                
                                et al.
                            
                            (2019). 
                            The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. 
                            Nature
                            , 575
                            (7781)
                            , 217-223.
                            https://doi.org/10.1038/s41586-019-1694-1
                        

Identifiers

DOI: 10.1038/s41586-019-1694-1